Biggest News Aggregation in the World
📰 Yantai News

Yantai News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Yantai. Real-time updates on events, politics, business and more.

RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88

YANTAI, China, June 3, 2024 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented the results of the first-in-human, single-arm, open-label, multi-center
United States Fang Jianmin Liu Yutao American Society Of Clinical Oncology Annual Meeting Chinese Academy Of Medical Sciences Cancer Hospital Prnewswire Remegen Co Ltd

Child psychologists advocate for inclusive efforts in dressing childhood autism

With International Childrens Day approaching, experts have gathered for training on the latest diagnostic criteria of autism spectrum disorder (ASD). Given the uncertainty surrounding the prevalence of ASD in children affected, specialists stressed the importance of early diagnoses to achieve better outcomes.
Jia Meixiang International Children Day University Sixth Hospital Children Rehabilitation Center With International Children Rehabilitation Center

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science